Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Other(4)

Detailed Status

Completed5
unknown4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown440%
completed550%
recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
recruiting

Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)

NCT07723560
completed

Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer

NCT04702633
completed

Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization

NCT06301919
completed

MYocardial DOmmages Related to COVID-19

NCT04498065
completednot_applicable

A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders

NCT05269927
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07723560

Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)

Recruiting
NCT04702633

Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer

Completed
NCT06301919

Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization

Completed
NCT04498065

MYocardial DOmmages Related to COVID-19

Completed
NCT05269927Not Applicable

A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders

Completed
NCT04498091

EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19

Unknown
NCT04374110

Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19

Unknown
NCT04141306

Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality

Unknown
NCT02398708

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

Completed
NCT01247441

Breast Cancer Registry - National University Health System, Singapore

Unknown

All 10 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
10